Summary
ABL Chart
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott (ABT) closed at $132.96 in the latest trading session, marking a -0.56% move from the prior day.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Laboratories Dividends
 ABL 7 months ago | Other | €0.55 Per Share |
| ABL 10 months ago | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
| ABL 12 Oct 2023 | Other | €0.51 Per Share |
Abbott Laboratories Earnings
| 16 Jul 2025 (41 Days) Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | - Cons. EPS | - EPS |
| 16 Oct 2024 Date | | - Cons. EPS | - EPS |
| 18 Jul 2024 Date | | - Cons. EPS | - EPS |
| ABL 7 months ago | Other | €0.55 Per Share |
| ABL 10 months ago | Other | €0.55 Per Share |
| ABL 12 Apr 2024 | Other | €0.55 Per Share |
| ABL 11 Jan 2024 | Other | €0.55 Per Share |
| ABL 12 Oct 2023 | Other | €0.51 Per Share |
| 16 Jul 2025 (41 Days) Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | - Cons. EPS | - EPS |
| 16 Oct 2024 Date | | - Cons. EPS | - EPS |
| 18 Jul 2024 Date | | - Cons. EPS | - EPS |
Abbott Laboratories (ABL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | XMUN Exchange | US0028241000 ISIN |
| US Country | 114,000 Employees | 15 Apr 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
